Treatment of light chain deposition disease with bortezomib and dexamethasone.
Kastritis
Efstathios
E
Migkou
Magdalini
M
Gavriatopoulou
Maria
M
Zirogiannis
Panos
P
Hadjikonstantinou
Valsamakis
V
Dimopoulos
Meletios A
MA
D000368:Aged; D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D003907:Dexamethasone / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010265:Paraproteinemias / Q000188:drug therapy*; D011719:Pyrazines / Q000627:therapeutic use*; D016896:Treatment Outcome
D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib; D003907:Dexamethasone